A Phase 1b/2 Study of Nanatinostat (Nstat) Plus Valganciclovir (VGCV) in Advanced Epstein-Barr Virus Positive (EBV+) Solid Tumors and with Pembrolizumab (PEM) in Recurrent/Metastatic Nasopharyngeal Carcinoma (RM-NPC)

Valcyte (valganciclovir) - Roche, Mitsubishi Tanabe

Keytruda (pembrolizumab) - Merck (MSD)

nanatinostat (VRx-3996) - Viracta Therap

D. Colevas1; L.L. Siu2; D.W. Lim3; B. Gao4; S.A. Khan5; L. Eng2; P.J. Voon6; M. Ahn7; A. Elguindy8; A. Katkov8; L. Rojkjaer8; Y. Katz8; B.B.Y. Ma9

Oct 21, 2022